REMEDY : BNSSG referral pathways & Joint Formulary

BNSSG Paediatric Joint Formulary
Home > Formulary : Paediatric > Recent Decisions > 2025 >

Decisions 28th January 2025

The following decisions were made at the Joint Formulary Group meeting held on Tuesday 28th January:

New Drug Requests

Sacubitril / Valsartan (Entresto) (TLS Red)

Other discussions/decisions

  • Potassium Chloride oral solution remains on the Paediatric formulary as TLS Red following the discontinuation of Kay-Cee-L syrup noting this is unlicensed